Carasent group signs contract to supply Ad Curis to Frelsesarmeen

24 Jun 2024 07:00 CEST

Frelsesarmeen and Carasent Norway have entered into an agreement to implement
the EHR system Ad Curis at Frelsesarmeen's addiction care and recovery clinics
in Norway. The annual recurring revenue from the contract is NOK 3.3 million.
The contract also includes NOK 6 million of consulting revenue.

Frelsesarmeen has 20 clinics providing addiction care and recovery, which will
now replace their current EHR with Ad Curis.

The yearly value of the contract after the implementation process is NOK 3.3
million, with an addition of NOK 6 million of consultancy revenue during the
implementation period, estimated to be from June until the end of 2025.

Carasent CEO Daniel Öhman comments:

| We are very pleased that Frelsesarmeen has chosen Ad Curis as their core
| system to support their forward-thinking digitalisation strategy.

| Carasent continues to win new contracts, ensuring accelerated and profitable
| growth. Signed but not implemented ARR is now approximately NOK 17 million,
| up from NOK 2 million in Q2 2024. Revenue growth is key to driving our
| profit margins, given that we aim to keep the cost base flat. This new ARR
| will contribute significantly, as our gross margins are over 80%.

About Ad Curis

Ad Curis is a cloud-based EHR software especially designed to meet the unique
needs of professionals working in addiction care and recovery. Its innovative
solutions streamline workflows and enhance the quality of care, empowering
healthcare providers to work more efficiently and in closer collaboration with
patients.

For further details please contact:

Daniel Öhman, CEO Tel: +46 70-855 37 07, or
Svein Martin Bjørnstad, CFO Tel: +47 979 69 493

More information:
Access the news on Oslo Bors NewsWeb site

622171_Carasent group signs contract to supply Ad Curis to Frelsesarmeen.pdf